How AI is helping scientists discover new drugs

Several idiopathic pulmonary fibrosis patients are testing a new drug developed using generative AI. — AFP Relaxnews

A few patients suffering from a rare disease are currently testing a new drug candidate based on a compound discovered using artificial intelligence. This new technology can save scientists an enormous amount of time compared to conventional research techniques.

A startup called Insilico Medicine, supported by Nvidia, is using generative artificial intelligence to design new drugs for rare diseases. These kinds of diseases affect some 300 million people worldwide, but only 5% have a cure.